<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="6680">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02083003</url>
  </required_header>
  <id_info>
    <org_study_id>2011/68</org_study_id>
    <nct_id>NCT02083003</nct_id>
  </id_info>
  <brief_title>Polyamine-low Diet to Prevent Postoperative Pain After Cholecystectomy</brief_title>
  <official_title>Polyamine-low Diet to Prevent Postoperative Pain After Cholecystectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hopital Foch</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hopital Foch</source>
  <oversight_info>
    <authority>France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      It has been shown that N-methyl-D-aspartate (NMDA) receptor antagonists (such as ketamine)
      potentiate analgesic drug's efficacy. Polyamines are allosteric modulators of NMDA
      receptors. In animal studies, polyamine-free diet has shown antinociceptive properties. This
      research aims at evaluating analgesic properties of polyamine-low diet after laparoscopic
      cholecystectomy performed in an ambulatory  setting.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Anticipated">August 2015</completion_date>
  <primary_completion_date type="Anticipated">January 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>Pain intensity for the 7 days</measure>
    <time_frame>7 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>Pain intensity is evaluated by the number of tablets of Tramadol taken by the patients</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain scores measured on the day of surgery,</measure>
    <time_frame>12 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>Pain score (numerical scale from 0 to 10) measured in mid-afternoon, resting lying down, coughing and mobilization (from lying to sitting position)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>frequency of impeded hospital discharge the day of surgery</measure>
    <time_frame>24 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>Failure of outpatient care (i.e. the patient cannot leave the hospital the day of surgery)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Each day pain</measure>
    <time_frame>7 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>Pain scores  (numerical scale from 0 to 10) assessed daily from J1 ( after surgery) to J7 in mid afternoon , lying at rest position , coughing and mobilization (from lying to sitting position) .</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>7 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>QLQC30 Questionnaire (version 3)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Residual pain</measure>
    <time_frame>30 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>Pain score (numerical scale from 0 to 10)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood levels of polyamine</measure>
    <time_frame>2 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>Blood samples are performed the day of surgery and at J7. The dosages will be performed when all patients will be recruited</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Surgery</condition>
  <arm_group>
    <arm_group_label>Polyamine low-diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Polyamines depleted diet during the week before surgery : 2 cans per day of Polydol (oral alimentation without polyamines), associated to predefined menus low in polyamines</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Liberal alimentation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>No specific alimentary diet</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Polyamine low-diet</intervention_name>
    <arm_group_label>Polyamine low-diet</arm_group_label>
    <other_name>Poyldol plus (Nutrialys)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Liberal alimentation</intervention_name>
    <arm_group_label>Liberal alimentation</arm_group_label>
    <other_name>No specific alimentary recommendation</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  laparoscopic cholecystectomy

          -  ambulatory surgery

          -  agreeing to follow a polyamine-low diet with Polydol plus

        Exclusion Criteria:

          -  Pregnancy

          -  Contra-indication to a non-steroidal anti-inflammatory, to tramadol

          -  Intolerance to cow proteins

          -  Diabetic patients

          -  Poor understanding of the French language.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>76 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marc Fischler, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Hopital Foch</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marc Fischler, MD</last_name>
    <phone>46252442</phone>
    <phone_ext>00331</phone_ext>
    <email>m.fischler@hopital-foch.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hôpital de la Croix Saint-Simon</name>
      <address>
        <city>Paris</city>
        <state>Hauts de Seine</state>
        <zip>75020</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>, Tandonnet</last_name>
      <phone>44641600</phone>
      <phone_ext>00331</phone_ext>
    </contact>
    <investigator>
      <last_name>Tandonnet, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>March 7, 2014</lastchanged_date>
  <firstreceived_date>March 7, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pain</keyword>
  <keyword>Polyamine</keyword>
  <keyword>Cholecystectomy</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
